Literature DB >> 28620809

Single gene reassortment of highly pathogenic avian influenza A H5N1 in the low pathogenic H9N2 backbone and its impact on pathogenicity and infectivity of novel reassortant viruses.

Yassmin Moatasim1, Ahmed Kandeil1, Ahmed Mostafa1, Sary Khaleel Abd Elghaffar2, Rabeh El Shesheny1, Ahmed Helmy M Elwahy3, Mohamed Ahmed Ali4.   

Abstract

Avian influenza A H5N1 and H9N2 viruses have been extensively circulating in various avian species and frequently infect mammals, including humans. The synchronous circulation of both viruses in Egypt provides an opportunity for possible genetic assortment, posing a probable threat to global public health. To assess the potential risk of the IAV reassortants derived from co-circulation of these two AI subtypes, reverse genetics technology was used to generate a set of IAV reassortants carrying single genetic segments of clade 2.2.1.2 virus A/duck/Egypt/Q4596D/2012 (H5N1), a representative of the most prevalent H5N1 clade in Egypt, in the genetic backbone of A/chicken/Egypt/S4456B/2011 (H9N2), a representative of G1-like H9N2 lineage which is widely circulating in Egypt. Furthermore, the genetic compatibility, growth kinetics and virulence were evaluated in vitro in mammalian systems using the MDCK cell line and avian system using SPF embryonated chicken eggs. Pathogenicity and virus shedding were further tested using SPF chickens. Out of the eight desired H9-reassortants, we could rescue only 5 reassortant viruses, either due to difficulty in cloning (PB1 of H5N1 virus) or genetic incompatibility (NP-H5/H9 and NA-H5/H9). Results revealed higher replication rates for the H9N2 virus having the NS segment of H5N1 virus. The lowest survival rate in both SPF eggs and SPF chickens was associated with the H5N1 parent virus infection, followed by the HA-H5/H9 virus. Our findings also suggest that all other reassortant viruses were of lower pathogenicity than the wild type H5N1 virus.

Entities:  

Mesh:

Year:  2017        PMID: 28620809     DOI: 10.1007/s00705-017-3434-x

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  5 in total

1.  Natural Reassortants of Potentially Zoonotic Avian Influenza Viruses H5N1 and H9N2 from Egypt Display Distinct Pathogenic Phenotypes in Experimentally Infected Chickens and Ferrets.

Authors:  Mahmoud M Naguib; Reiner Ulrich; Elisa Kasbohm; Christine L P Eng; Donata Hoffmann; Christian Grund; Martin Beer; Timm C Harder
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

2.  Genetic Compatibility of Reassortants between Avian H5N1 and H9N2 Influenza Viruses with Higher Pathogenicity in Mammals.

Authors:  Yasuha Arai; Madiha S Ibrahim; Emad M Elgendy; Tomo Daidoji; Takao Ono; Yasuo Suzuki; Takaaki Nakaya; Kazuhiko Matsumoto; Yohei Watanabe
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

3.  Avian influenza A (H9N2) virus infections among poultry workers, swine workers, and the general population in Beijing, China, 2013-2016: A serological cohort study.

Authors:  Chunna Ma; Shujuan Cui; Ying Sun; Jiachen Zhao; Daitao Zhang; Li Zhang; Yi Zhang; Yang Pan; Shuangsheng Wu; Wei Duan; Man Zhang; Peng Yang; Quanyi Wang
Journal:  Influenza Other Respir Viruses       Date:  2019-03-18       Impact factor: 4.380

4.  Genetic, Molecular, and Pathogenic Characterization of the H9N2 Avian Influenza Viruses Currently Circulating in South China.

Authors:  Hailiang Sun; Jiate Lin; Zhiting Liu; Yanan Yu; Meihua Wu; Shuo Li; Yang Liu; Yaling Feng; Yuqian Wu; Mingliang Li; Peirong Jiao; Kaijian Luo; Ming Liao
Journal:  Viruses       Date:  2019-11-08       Impact factor: 5.048

5.  PA from a Recent H9N2 (G1-Like) Avian Influenza a Virus (AIV) Strain Carrying Lysine 367 Confers Altered Replication Efficiency and Pathogenicity to Contemporaneous H5N1 in Mammalian Systems.

Authors:  Ahmed Mostafa; Sara H Mahmoud; Mahmoud Shehata; Christin Müller; Ahmed Kandeil; Rabeh El-Shesheny; Hanaa Z Nooh; Ghazi Kayali; Mohamed A Ali; Stephan Pleschka
Journal:  Viruses       Date:  2020-09-20       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.